Clinical Trial Update: B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate Kinase Deficiency

View source ↗

Summary

The trial NCT01568736 investigating B7 coreceptor molecules in Hyper IgD Syndrome form of Mevalonate Kinase Deficiency has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyper-igd Syndrome
• Mevalonate Kinase Deficiency

Snippet

Sponsor: Michigan Technological University | Conditions: Hyper IgD Syndrome, Mevalonate Kinase Deficiency | Status: WITHDRAWN